Eurocine Vaccines discloses interim report for Juli – September 2023
Eurocine Vaccines AB (publ) (”Eurocine Vaccines) hereby discloses the interim report for July to September 2023. Below is a summary of the report. The full report is available on the Eurocine Vaccines website and as an attachment. 2023-07-01 - 2023-09-30 (first quarter) · Results after tax for the quarter amounted to -2 022 KSEK (-5 880 KSEK) · Revenues for the quarter amounted to 0 KSEK (0 KSEK) · Earnings per share for the quarter amounted to -0,039 SEK (-0,339 SEK)Highlights during the period Eurocine Vaccines held an Extraordinary